JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 23, 2003; DOI: 10.1124/jpet.103.053017


0022-3565/03/3063-980-987$20.00
JPET 306:980-987, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.053017v1
306/3/980    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tosaka, T.
Right arrow Articles by Ebert, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosaka, T.
Right arrow Articles by Ebert, S. N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NICOTINE
*NICOTINE TARTRATE

CARDIOVASCULAR

Nicotine Induces a Long QT Phenotype in Kcnq1-Deficient Mouse Hearts

Toshimasa Tosaka, Mathew C. Casimiro, Qi Rong, Srihari Tella, Michelle Oh, Alexander N. Katchman, John C. Pezzullo, Karl Pfeifer, and Steven N. Ebert

Department of Pharmacology, Georgetown University Medical Center, Washington, DC (T.T., Q.R., M.O., A.N.K., J.C.P., S.N.E.); Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development/National Institutes of Health, Bethesda, Maryland (M.C.C., K.P.); Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration, Washington DC (S.T.)

We have previously shown that targeted disruption of the mouse Kcnq1 gene produces a long QT phenotype in vivo that requires extracardiac factors for manifestation (Casimiro et al., 2001). In the present study, we explore the hypothesis that autonomic neuroeffector transmission represents the "extra cardiac" stimulus that induces a long QT phenotype in mouse hearts lacking Kcnq1. Using the isolated perfused (Langendorff) mouse heart preparation, we challenged wild-type (Kcnq1+/+) and mutant (Kcnq1-/-) mouse hearts with nicotine, an autonomic stimulant. ECGs were recorded continuously, and QT intervals were compared at baseline and peak nicotine-induced heart rates. No significant differences in QT or any other ECG parameters were observed in Kcnq1+/+ versus Kcnq1-/- hearts at baseline. In the presence of nicotine, however, the JT, QT, and rate-corrected QT (QTc) intervals were significantly prolonged in Kcnq1-/- hearts relative to Kcnq1+/+ hearts (e.g., QTc = 92 ± 11 ms versus 66 ± 2 ms, respectively, p < 0.01). Similar findings were obtained when the hearts were challenged with either epinephrine or isoproterenol (0.1 µM each), thereby suggesting that sympathetic stimulation drives the long QT phenotype in Kcnq1-deficient hearts. This idea is supported by in vivo ECG data obtained from unrestrained conscious mice using radiotelemetry recording techniques. Again, no significant ECG differences were observed in Kcnq1-/- versus Kcnq1+/+ mice at baseline, but handling/injection stress led to significant QTc increases in Kcnq1-/- mice relative to wild-type controls (11 ± 3 versus -1 ± 1%, respectively, p < 0.05). These data suggest that sympathetic stimulation induces a long QT phenotype in Kcnq1-deficient mouse hearts.


Received April 11, 2003; accepted May 14, 2003.

Address correspondence to: Dr. Steven N. Ebert, Department of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC 20057. E-mail: eberts{at}georgetown.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Suto, W. Zhu, A. Chan, and G. J. Gross
IKr and IKs remodeling differentially affects QT interval prolongation and dynamic adaptation to heart rate acceleration in bradycardic rabbits
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1782 - H1788.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Thomas, M. J. Killeen, I. S. Gurung, P. Hakim, R. Balasubramaniam, C. A. Goddard, A. A. Grace, and C. L.-H. Huang
Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5
J. Physiol., January 1, 2007; 578(1): 99 - 114.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. Gohma, T. Kuramoto, M. Kuwamura, R. Okajima, N. Tanimoto, K.-i. Yamasaki, S. Nakanishi, K. Kitada, T. Makiyama, M. Akao, et al.
WTC deafness Kyoto (dfk): a rat model for extensive investigations of Kcnq1 functions
Physiol Genomics, February 23, 2006; 24(3): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. C. Knollmann, M. C. Casimiro, A. N. Katchman, S. G. Sirenko, T. Schober, Q. Rong, K. Pfeifer, and S. N. Ebert
Isoproterenol Exacerbates a Long QT Phenotype in Kcnq1-Deficient Neonatal Mice: Possible Roles for Human-Like Kcnq1 Isoform 1 and Slow Delayed Rectifier K+ Current
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 311 - 318.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.